do-me/EUR-LEX huggingface dataset:
Euro exchange rates (Source: reference exchange rate published by the ECB.) 14 June 2021 2021/C 229/01
Date: 2021-06-15
Institutions: European Commission
Subjects: euro, exchange rate, money








C_2021229EN.01000101.xml










15.6.2021   


EN


Official Journal of the European Union


C 229/1






Euro exchange rates (1)

14 June 2021
(2021/C 229/01)

1 euro =











 


Currency


Exchange rate




USD


US dollar


1,2112 




JPY


Japanese yen


132,95 




DKK


Danish krone


7,4361 




GBP


Pound sterling


0,85898 




SEK


Swedish krona


10,0944 




CHF


Swiss franc


1,0889 




ISK


Iceland króna


147,20 




NOK


Norwegian krone


10,0828 




BGN


Bulgarian lev


1,9558 




CZK


Czech koruna


25,422 




HUF


Hungarian forint


351,14 




PLN


Polish zloty


4,5152 




RON


Romanian leu


4,9203 




TRY


Turkish lira


10,1380 




AUD


Australian dollar


1,5696 




CAD


Canadian dollar


1,4737 




HKD


Hong Kong dollar


9,4008 




NZD


New Zealand dollar


1,6959 




SGD


Singapore dollar


1,6070 




KRW


South Korean won


1 355,07 




ZAR


South African rand


16,7159 




CNY


Chinese yuan renminbi


7,7501 




HRK


Croatian kuna


7,4890 




IDR


Indonesian rupiah


17 267,62 




MYR


Malaysian ringgit


4,9841 




PHP


Philippine peso


57,969 




RUB


Russian rouble


87,5040 




THB


Thai baht


37,717 




BRL


Brazilian real


6,1846 




MXN


Mexican peso


24,1179 




INR


Indian rupee


88,7015 






(1)  Source: reference exchange rate published by the ECB.
Notice for the attention of certain persons and entities subject to the restrictive measures provided for in Council Decision (CFSP) 2016/849 and Council Regulation (EU) 2017/1509 concerning restrictive measures against the Democratic People’s Republic of Korea 2021/C 229 I/01
Date: 2021-06-15
Institutions: Council of the European Union
Subjects: EU restrictive measure, North Korea, economic sanctions, international sanctions, legal person, natural person








CI2021229EN.01000101.xml










15.6.2021   


EN


Official Journal of the European Union


CI 229/1






Notice for the attention of certain persons and entities subject to the restrictive measures provided for in Council Decision (CFSP) 2016/849 and Council Regulation (EU) 2017/1509 concerning restrictive measures against the Democratic People’s Republic of Korea
(2021/C 229 I/01)
The following information is brought to the attention of Mr. Ri Pyong Chul (no. 77) appearing in Annex I to Council Decision (CFSP) 2016/849 and Annex XIII to Regulation (EU) 2017/1509 (1), as well as Mr. SO Sang-kuk (no. 6), KIM Yong Chol (no. 7), Mr. HONG Sung-Mu (no. 10), Mr. JO Kyongchol (no. 11), Mr. KIM Rak Kyom (no. 15), Mr. KIM Won-hong (no. 16), Mr. PAK Jong-chon (no. 17), Mr. RI Jong-su (no. 18), Mr. SON Chol-ju (no. 19), Mr. RI Myong Su (no. 24), Mr. SO Hong Chan (no.25), and Yongbyon Nuclear Research Centre (no. 4), persons and entity appearing in section I of Annex II to Decision (CFSP) 2016/849 (2) and in Annex XV to Regulation (EU) 2017/1509 (3), as well as Mr. KIM Tong-un (no. 2) person appearing in section II of Annex II to Decision (CFSP) 2016/849 (4) and in Annex XV to Regulation (EU) 2017/1509 (5) as well as Mr. YUN Chol (no. 6), person appearing in Annex III to Decision (CFSP) 2016/849 and in Annex XVI to Regulation (EU) 2017/1509 concerning restrictive measures against the Democratic People’s Republic of Korea.
The Council intends to maintain the restrictive measures against the above-mentioned persons and entities with new statements of reasons. Those persons are hereby informed that they may submit a request to the Council to obtain the intended statements of reasons for their designation, before 28 June 2021, to the following address:





Council of the European Union




General Secretariat




RELEX.1.C




Rue de la Loi/Wetstraat 175




1048 Bruxelles/Brussel




BELGIQUE/BELGIË




Email: sanctions@consilium.europa.eu


(1)  OJ L 224, 31.8.2017, p. 1.

(2)  OJ L 141, 28.5.2016, p. 79.

(3)  OJ L 224, 31.8.2017, p. 1.

(4)  OJ L 141, 28.5.2016, p. 79.

(5)  OJ L 224, 31.8.2017, p. 1.
Statement by the Commission
Date: 2021-06-15
Institutions: European Commission
Subjects: EU Member State, EU national, border control, coronavirus disease, epidemic, foreign national, free movement of persons, health certificate, health control, vaccination








L_2021211EN.01002301.xml










15.6.2021   


EN


Official Journal of the European Union


L 211/23








            STATEMENT BY THE COMMISSION
         

The Commission agrees that affordable and accessible COVID-19 vaccines and tests for SARS-CoV-2 infection are crucial in the fight against the COVID-19 pandemic. Taking into account that not the entire population will have been vaccinated when Regulations (EU) 2021/953 and (EU) 2021/954 of the European Parliament and of the Council enter into force, access to affordable and widely available testing possibilities is important to facilitate free movement and mobility in Europe.
To support Member States’ testing capacities, the Commission has already mobilised funds under the Emergency Support Instrument to purchase rapid antigen tests and has launched a joint procurement for over half a billion rapid antigen tests. The International Federation of Red Cross is also supporting Member States to increase testing capacity, using funding from the Emergency Support Instrument.
To further support the availability of affordable tests, in particular for persons who cross borders daily or frequently to go to work or school, visit close relatives, seek medical care, or to take care of loved ones, the Commission commits to mobilise additional funds of EUR 100 million under the Emergency Support Instrument for the purchase of tests for SARS-CoV-2 infection that qualify for the issuance of a test certificate pursuant to Regulation Regulations (EU) 2021/953 If necessary, additional funding above EUR 100 million could be mobilised, subject to approval by the budgetary authority.
Case T-336/21: Action brought on 15 June 2021 — Mendus v EUIPO (CENSOR.NET)
Date: 2021-06-15
Institutions: General Court
Subjects: EU trade mark, Internet site, advertising, registered trade mark, rental business, trade information, trade-mark law








C_2021320EN.01004701.xml










9.8.2021   


EN


Official Journal of the European Union


C 320/47






Action brought on 15 June 2021 — Mendus v EUIPO (CENSOR.NET)
(Case T-336/21)
(2021/C 320/53)
Language of the case: English

Parties


Applicant: Iaroslav Mendus (Kiev, Ukraine) (represented by: P. Kurcman, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Details of the proceedings before EUIPO


Trade mark at issue: Application for European Union word mark CENSOR.NET — Application for registration No 17 975 929

Contested decision: Decision of the First Board of Appeal of EUIPO of 16 April 2021 in Case R 1225/2020-1

Form of order sought

The applicant claims that the Court should:






—


annul the contested decision in respect of services for which registration has been refused;










—


annul the decision of Operations Division dated 17 April 2020 in application procedure No 17 975 929 in respect of services for which registration has been refused;










—


refer the case back to EUIPO so it can amend the decision on the substance of the case and register European Union trade mark No 17 975 929 in respect of all the services covered;










—


charge EUIPO with the costs of the proceedings before the Operations Division, Board of Appeal and General Court.





Plea in law







—


Infringement of Article 7(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.
Calls for proposals and related activities under the 2021-2022 work programme under Horizon Europe – the Framework Programme for Research and Innovation (2021-2027) 2021/C 229/06
Date: 2021-06-15
Institutions: Directorate-General for Research and Innovation, European Commission
Subjects: EU programme, Framework Programme for Research and Development, action programme, innovation, invitation to tender, research and development








C_2021229EN.01001901.xml










15.6.2021   


EN


Official Journal of the European Union


C 229/19






Calls for proposals and related activities under the 2021-2022 work programme under Horizon Europe – the Framework Programme for Research and Innovation (2021-2027)
(2021/C 229/06)
Notice is hereby given of the launch of further actions under the 2021-2022 work programme under Horizon Europe – the Framework Programme for Research and Innovation (2021-2027).
The Commission has adopted an amendment to the above mentioned work programme by Decision C(2021) 4200 of 15 June 2021.
The actions are subject to the availability of the appropriations provided for in the general budget of the Union for 2021 and 2022, following the adoption of the 2022 budget by the budgetary authority or as provided for in the system of provisional twelfths. The Commission reserves its right to cancel or make corrigendum to the actions.
Confirmation that these conditions have been met will be announced on the European Commission Funding & Tenders Portal website (https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/programmes/horizon).
This work programme, including deadlines and budgets for the actions, are available through the above-mentioned Funding & Tenders Portal along with information on the modalities of the actions, and guidance for applicants on how to submit proposals. All this information will be updated as necessary on the same Funding & Tenders Portal.
Case T-335/21: Action brought on 15 June 2021 — PJ v EIT
Date: 2021-06-15
Institutions: General Court
Subjects: competence of the institution, interpretation of the law, principle of legal certainty, protection of privacy, rights of the defence, staff regulations (EU), teleworking, work-life balance








C_2021310EN.01003901.xml










2.8.2021   


EN


Official Journal of the European Union


C 310/39






Action brought on 15 June 2021 — PJ v EIT
(Case T-335/21)
(2021/C 310/52)
Language of the case: French

Parties


Applicant: PJ (represented by: N. de Montigny, lawyer)

Defendant: European Institution of Innovation & Technology

Form of order sought

The applicant claims that the Court should:






—


annul the executive director’s decision of 13 October 2020 refusing her the benefit of teleworking from her place of origin;










—


in so far as necessary, annul the executive director’s decision of 9 March 2021 rejecting the applicant’s complaint lodged on 10 November 2020;










—


order the defendant to pay all the costs.





Pleas in law and main arguments

In support of the action, the applicant relies on eight pleas in law.






1.


First plea in law, alleging infringement of the duty of impartiality, objectivity and neutrality of the authority empowered to conclude contracts of employment, and the adoption of internal rules by an authority lacking competence to do so.










2.


Second plea in law, alleging infringement of the right to be heard.










3.


Third plea in law, alleging a failure to state reasons.










4.


Fourth plea in law, alleging infringement of internal rules, and arbitrary and unreasonable interpretation of such rules, as well as a lack of predictability and of legal certainty.










5.


Fifth plea in law, alleging infringement of the duty to care towards staff, a failure to take into account the interests of both the institution and the applicant, and the disproportionate nature of the decision in view of the actual interest of the institution.










6.


Sixth plea in law, alleging infringement of the right to respect for private and family life set out in Article 7 of the Charter of Fundamental Rights of the European Union (‘the Charter’) as well as the right to a work-life balance set out in Article 33 of the Charter.










7.


Seventh plea in law, alleging infringement of the effective right to employment and failure to provide fair working conditions.










8.


Eighth plea in law, alleging a failure to take into consideration a force majeure event.
Non-opposition to a notified concentration (Case M.10272 — Utmost/Quilter International) (Text with EEA relevance) 2021/C 244/01
Date: 2021-06-15
Institutions: Directorate-General for Competition, European Commission
Subjects: economic concentration, investment company, life assurance, merger control








C_2021244EN.01000101.xml










22.6.2021   


EN


Official Journal of the European Union


C 244/1






Non-opposition to a notified concentration
(Case M.10272 — Utmost/Quilter International)
(Text with EEA relevance)
(2021/C 244/01)
On 15 June 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10272. EUR-Lex is the online access to European law.






(1)  OJ L 24, 29.1.2004, p. 1.
Statement by the Commission
Date: 2021-06-15
Institutions: European Commission
Subjects: EU Member State, EU national, border control, coronavirus disease, epidemic, foreign national, free movement of persons, health certificate, health control, vaccination








L_2021211EN.01002901.xml










15.6.2021   


EN


Official Journal of the European Union


L 211/29








            STATEMENT BY THE COMMISSION
         

The Commission agrees that affordable and accessible COVID-19 vaccines and tests for SARS-CoV-2 infection are crucial in the fight against the COVID-19 pandemic. Taking into account that not the entire population will have been vaccinated when Regulations (EU) 2021/953 and (EU) 2021/954 of the European Parliament and of the Council enter into force, access to affordable and widely available testing possibilities is important to facilitate free movement and mobility in Europe.
To support Member States’ testing capacities, the Commission has already mobilised funds under the Emergency Support Instrument to purchase rapid antigen tests and has launched a joint procurement for over half a billion rapid antigen tests. The International Federation of Red Cross is also supporting Member States to increase testing capacity, using funding from the Emergency Support Instrument.
To further support the availability of affordable tests, in particular for persons who cross borders daily or frequently to go to work or school, visit close relatives, seek medical care, or to take care of loved ones, the Commission commits to mobilise additional funds of EUR 100 million under the Emergency Support Instrument for the purchase of tests for SARS-CoV-2 infection that qualify for the issuance of a test certificate pursuant to Regulation (EU) 2021/953 If necessary, additional funding above EUR 100 million could be mobilised, subject to approval by the budgetary authority.
Case C-370/21: Request for a preliminary ruling from the Landgericht München (Germany) lodged on 15 June 2021 — DOMUS-SOFTWARE-AG v Marc Braschoß Immobilien GmbH
Date: 2021-06-15
Institutions: Court of Justice
Subjects: claim, commercial transaction, legal expenses, payment








C_2021349EN.01002201.xml










30.8.2021   


EN


Official Journal of the European Union


C 349/22






Request for a preliminary ruling from the Landgericht München (Germany) lodged on 15 June 2021 — DOMUS-SOFTWARE-AG v Marc Braschoß Immobilien GmbH
(Case C-370/21)
(2021/C 349/27)
Language of the case: German

Referring court

Landgericht München

Parties to the main proceedings


Appellant: DOMUS-SOFTWARE-AG

Respondent: Marc Braschoß Immobilien GmbH

Question referred

Is Article 6(1) and (2) of Directive 2011/7/EU, (1) read in conjunction with Article 3 of Directive 2011/7/EU, to be interpreted as meaning that, in the case of periodic claims for payment arising from a single contractual relationship, there is an entitlement to payment of a fixed sum of at least EUR 40 for each individual claim for payment?


(1)  Directive 2011/7/EU of the European Parliament and of the Council of 16 February 2011 on combating late payment in commercial transactions (recast) (OJ 2011 L 48, p. 1).